The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years ...

A recent study in Nature Neuroscience provides new insights into how amyloid-beta and tau proteins, which accumulate in the ...

APOE4 carriers had higher blood-brain barrier permeability, even without cognitive decline or amyloid beta buildup, ...

A curious link between Alzheimer's and insulin resistance is now so well-established, the neurodegenerative disease is ...

In mice, inhibiting protein S-palmitoylation Counteracted accumulation of harmful proteins in neurons and delayed onset and progression of cognitive decline.

Brain volume loss linked to new Alzheimer’s immunotherapies, such as lecanemab, is caused by the removal of amyloid plaques rather than neuronal damage.

Complex problems often require creative solutions, and the increasing global burden of Alzheimer’s disease certainly ...

Alzheimer's & Dementia: Diagnosis, Assessment, & Disease Monitoring. Which method is better? Basically, there are two approved methods for identifying the presence of dangerous amyloid plaques in ...

The "Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Dementia Associated With Alzheimer's Disease - ...

A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a study led ...

Disease Monitoring. Basically, there are two approved methods for identifying the presence of dangerous amyloid plaques in the brains of Alzheimer's patients. Method number 1 involves analyzing ...

One of the hallmarks of Alzheimer’s disease is the formation of protein plaques and tangles between nerve cells. These are made of so-called beta-amyloid fragments that stick together and accumulate ...